EIF2B3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.465400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.213800E-01
Normal-vs-Stage2
9.827600E-01
Normal-vs-Stage3
8.133600E-01
Normal-vs-Stage4
9.199800E-01
Stage1-vs-Stage2
7.580000E-01
Stage1-vs-Stage3
7.224800E-01
Stage1-vs-Stage4
9.181600E-01
Stage2-vs-Stage3
6.452800E-01
Stage2-vs-Stage4
9.572600E-01
Stage3-vs-Stage4
7.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.273200E-01
Normal-vs-AfricanAmerican
7.560800E-01
Normal-vs-Asian
5.304800E-01
Caucasian-vs-AfricanAmerican
8.150800E-01
Caucasian-vs-Asian
3.054000E-01
AfricanAmerican-vs-Asian
2.463600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.304800E-01
Normal-vs-Female
8.188200E-01
Male-vs-Female
2.021800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.694200E-01
Normal-vs-Age(41-60Yrs)
6.330600E-01
Normal-vs-Age(61-80Yrs)
8.554000E-01
Normal-vs-Age(81-100Yrs)
7.181600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.844400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.084600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.787400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.804180E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.682400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.613600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.396600E-01
Normal-vs-Daily Drinker
7.838800E-01
Normal-vs-Weekly Drinker
9.252800E-01
Normal-vs-Occasional Drinker
6.115600E-01
Normal-vs-Social Drinker
6.437400E-01
Non Drinker-vs-Daily Drinker
9.819200E-01
Non Drinker-vs-Weekly Drinker
6.582000E-01
Non Drinker-vs-Occasional Drinker
1.592760E-01
Non Drinker-vs-Social Drinker
2.509600E-01
Daily Drinker-vs-Weekly Drinker
6.438200E-01
Daily Drinker-vs-Occasional Drinker
1.269210E-01
Daily Drinker-vs-Social Drinker
1.829020E-01
Weekly Drinker-vs-Occasional Drinker
6.443400E-01
Weekly Drinker-vs-Social Drinker
7.835000E-01
Occasional Drinker-vs-Social Drinker
7.951800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.943400E-01
Normal-vs-Grade 2
7.343000E-01
Normal-vs-Grade 3
7.183600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.058300E-02
Grade 1-vs-Grade 3
3.939400E-01
Grade 1-vs-Grade 4
6.943400E-01
Grade 2-vs-Grade 3
4.332600E-01
Grade 2-vs-Grade 4
7.343000E-01
Grade 3-vs-Grade 4
7.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.187000E-01
Normal-vs-NonDiabetic
9.812200E-01
Diabetic-vs-NonDiabetic
6.859800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.106200E-01
Normal-vs-NoPancreatitis
9.825000E-01
Pancreatitis-vs-NoPancreatitis
4.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.603200E-01
Normal-vs-N1
9.908000E-01
N0-vs-N1
2.976400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.248600E-01
Normal-vs-TP53-NonMutant
7.496800E-01
TP53-Mutant-vs-TP53-NonMutant
4.946200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
